Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Biliary Tract Tumors”

497 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 497 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04969887
What this trial is testing

Combination Immunotherapy in Rare Cancers Under InvesTigation

Who this might be right for
Advanced Biliary Tract CancerNeuroendocrine TumorsFemale Reproductive System Neoplasm+1 more
Olivia Newton-John Cancer Research Institute 240
Testing effectiveness (Phase 2)Study completedNCT03486678
What this trial is testing

SHR-1210 in Combination With GEMOX in Patients With Advanced BTC

Who this might be right for
Biliary Tract CancerCholangiocarcinoma
The First Affiliated Hospital with Nanjing Medical University 38
Testing effectiveness (Phase 2)UnknownNCT05527821
What this trial is testing

Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid Tumors

Who this might be right for
Unresectable Advanced Solid TumorsBiliary Tract Tumors, Gastric Cancer, Small Cell Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Not applicableUnknownNCT05051358
What this trial is testing

Therapeutic Endoscopic Ultrasound for Gastrointestinal Disorders: A Multicenter Registry Study

Who this might be right for
Therapeutic Endoscopic UltrasoundAdvanced EndoscopyTherapeutic Endoscopy+11 more
Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University 5,000
Testing effectiveness (Phase 2)Study completedNCT00003276
What this trial is testing

Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer

Who this might be right for
Gallbladder Cancer
Alliance for Clinical Trials in Oncology 40
Not applicableLooking for participantsNCT06648057
What this trial is testing

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

Who this might be right for
Biliary Tract CancerCholangiocarcinoma
CHA University 100
Testing effectiveness (Phase 2)Study completedNCT02829918
What this trial is testing

Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers

Who this might be right for
Biliary Tract CancerBiliary Tract Neoplasms
H. Lee Moffitt Cancer Center and Research Institute 54
Not applicableNo Longer AvailableNCT04578444
What this trial is testing

An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer

Who this might be right for
HER2-Positive Advanced Biliary Tract Cancer
Jazz Pharmaceuticals
Not applicableWithdrawnNCT03419247
What this trial is testing

Molecular Profiling of Advanced Biliary Tract Cancers

Who this might be right for
Biliary Tract Cancer
University Health Network, Toronto
Testing effectiveness (Phase 2)UnknownNCT06074029
What this trial is testing

Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy

Who this might be right for
Biliary Tract CancerImmune Checkpoint InhibitorPredictive Cancer Model
Peking Union Medical College Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06730581
What this trial is testing

Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors

Who this might be right for
Gastric Cancer Adenocarcinoma MetastaticOvarian CancerBile Duct Cancer
Beijing Biostar Pharmaceuticals Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT03833661
What this trial is testing

M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer
EMD Serono Research & Development Institute, Inc. 159
Testing effectiveness (Phase 2)Active Not RecruitingNCT05994001
What this trial is testing

Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody

Who this might be right for
Biliary Tract CancerCandonilimabClaudin 18.2
Shanghai Zhongshan Hospital 78
Testing effectiveness (Phase 2)Study completedNCT02433639
What this trial is testing

Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Seoul National University Hospital 24
Testing effectiveness (Phase 2)UnknownNCT03144856
What this trial is testing

Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers

Who this might be right for
Biliary Tract Cancer
Sun Yat-sen University 39
Early research (Phase 1)Ended earlyNCT04178460
What this trial is testing

Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment

Who this might be right for
Gastric CancerTriple Negative Breast CancerBiliary Tract Carcinoma+1 more
Zai Lab (Shanghai) Co., Ltd. 60
Testing effectiveness (Phase 2)Ended earlyNCT01855724
What this trial is testing

Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer

Who this might be right for
CholangiocarcinomaGallbladder CarcinomaBiliary Carcinoma
Hellenic Cooperative Oncology Group 29
Testing effectiveness (Phase 2)Study completedNCT04666688
What this trial is testing

LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorPancreatic Cancer+3 more
PureTech 44
Testing effectiveness (Phase 2)UnknownNCT05653180
What this trial is testing

IBI310 in Combination With Sintilimab in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer
Innovent Biologics (Suzhou) Co. Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT03406299
What this trial is testing

Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Biliary Tract Neoplasms
National Health Research Institutes, Taiwan 92
Next Page